MedTrace Logo

Follow-up Strategy of Chronic Hepatitis B for Early Detection and Diagnosis of Hepatocellular Carcinoma: A Randomized Control Trial

NCT02817685 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 7660

Last updated 2016-06-29

No results posted yet for this study

Summary

This study is a randomized control prospective study. The aim of this study is to establish an all-round and convenient follow-up strategy of Chronic Hepatitis B for early detection and diagnosis of Hepatocellular Carcinoma (HCC), by investigating whether different surveillance time intervals and surveillance methods are beneficial for chronic hepatitis B and cirrhotic patients with different risk of HCC.

Conditions

Interventions

OTHER

3 months

OTHER

6 months

OTHER

3 month ultrasound(US)+3 month CT/MRI+3 month US+3 month CT/MRI

Sponsors & Collaborators

  • Third Affiliated Hospital, Sun Yat-Sen University

    lead OTHER

Principal Investigators

  • zhongzhen zz Su, doctor · The department of Ultrasound, the third affiliated hospital of Sun Yat-sen University

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2020-05-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02817685 on ClinicalTrials.gov